The Food and Drug Administration (FDA) has accepted for review the New Drug Application (NDA) for CTx-1301 for the treatment of attention deficit/hyperactivity disorder (ADHD) in children and adults.
ADHD in women often goes undiagnosed because its symptoms can differ from the classic hyperactive behavior typically seen in ...
Once-daily Precision Timed Release™ (PTR™) stimulant designed to deliver rapid onset of effect and entire active-day duration ...
Arynta is a medicine used to treat attention deficit hyperactivity disorder (ADHD). ADHD is a common condition in children, and it also affects adults. ADHD affects how you pay attention, focus, and ...
Attention improved in more than 80 percent of adults with ADHD, and over one-third of participants no longer exhibited an attention deficit following treatment Improvements in attention were nearly ...
A once-daily oral stimulant medication for treatment of attention-deficit/hyperactivity disorder (ADHD) in individuals aged 6 years or older is safe and effective ...
EndeavorRx is authorized for use to improve attention function in adolescents with primarily inattentive or combined-type ADHD. The Food and Drug Administration (FDA) has expanded the approval of ...
From fidgeting to being overly-emotional, here are a few signs that show your child might have Attention Deficit Hyperactivity Disorder (ADHD), Health, Times Now ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback